Advertisement

AIDS and Behavior

, Volume 21, Issue 4, pp 1183–1207 | Cite as

Social Network Strategies to Address HIV Prevention and Treatment Continuum of Care Among At-risk and HIV-infected Substance Users: A Systematic Scoping Review

  • Debarchana Ghosh
  • Archana Krishnan
  • Britton Gibson
  • Shan-Estelle Brown
  • Carl A. Latkin
  • Frederick L. Altice
Original Paper

Abstract

Social network analysis (SNA) and social network-based interventions (SNI) are important analytical tools harnessing peer and family influences critical for HIV prevention and treatment among substance users. While SNA is an effective way to measure social network influences, SNI directly or indirectly involves network members in interventions. Even though these methods have been applied in heterogeneous ways, leading to extensive evidence-based practices, systematic reviews are however, lacking. We searched five bibliographic databases and identified 58 studies involving HIV in substance users that had utilized SNA or SNI as part of their methodology. SNA was used to measure network variables as inputs in statistical/mathematical models in 64 % of studies and only 22 % of studies used SNI. Most studies focused on HIV prevention and few addressed diagnosis (k = 4), care linkage and retention (k = 5), ART adherence (k = 2), and viral suppression (k = 1). This systematic review highlights both the advantages and disadvantages of social network approaches for HIV prevention and treatment and gaps in its use for HIV care continuum.

Keywords

Social network analysis Social network intervention HIV prevention HIV care continuum Substance users 

Notes

Acknowledgments

The authors would like to thank Librarian Janis Glover from Yale University for assistance with search strategy and comprehensive searches from the multiple databases. For this study, the authors DG (K01DA037794) and FLA (K24DA017072 and R01DA030768) were funded by the National Institute of Health.

Funding

This study was funded by the National Institute of Health (K01DA037794; K24DA017072 and R01DA030768).

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. 1.
    Joint United Nations Programme on HIV/AIDS. 90-90-90- An ambitious treatment target to help end the AIDS epidemic New York. 2014. http://www.unaids.org/en/resources/documents/2014/2090-2090-2090.
  2. 2.
    Kamarulzaman A, Altice FL. Challenges in managing HIV in people who use drugs. Curr Opin Infect Dis. 2015;28(1):10–6.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Cook C, Bridge J, McLean S, Phelan M, Barrett D. The funding crisis for harm reduction: donor retreat, government neglect and the way forward. London: International Harm Reduction Association; 2014.Google Scholar
  4. 4.
    Stein J, Newcomb M, Bentler PM. An 8-year study of multiplt influences on drug use consequences. J Pers Soc Psychol. 1987;53:1094–105.CrossRefPubMedGoogle Scholar
  5. 5.
    Krishnan A, Brown SE, Ghani M, Khan F, Kamarulzaman A, Altice FL. Pre-treatment drug use characteristics and experiences among patients in a voluntary substance abuse treatment center in Malaysia: a mixed methods approach. Subst Abus. 2016;. doi: 10.1080/08897077.2016.1146648.PubMedGoogle Scholar
  6. 6.
    Wu J, Witkiewitz K. Network support for drinking: an application of multiple groups growth mixture modeling to examine client-treatment matching. J Stud Alcohol. 2008;69(1):21–9.CrossRefGoogle Scholar
  7. 7.
    Wu LT, Ling W, Burchett B, Blazer DG, Yang C, Pan JJ, et al. Use of item response theory and latent class analysis to link poly-substance use disorders with addiction severity, HIV risk, and quality of life among opioid-dependent patients in the Clinical Trials Network. Drug Alcohol Depend. 2011;118(2–3):186–93.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Kimbrough LW, Fisher HE, Jones KT, Johnson W, Thadiparthi S, Dooley S. Accessing social networks with high rates of undiagnosed HIV infection: the social networks demonstration project. Am J Public Health. 2009;99(6):1093–9.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Gorbach PM, Sopheab H, Phalla T, Leng HB, Mills S, Bennett A, et al. Sexual bridging by Cambodian men—potential importance for general population spread of STD and HIV epidemics. Sex Transm Dis. 2000;27(6):320–6.CrossRefPubMedGoogle Scholar
  10. 10.
    Jenness SM, Neaigus A, Hagan H, Murrill CS, Wendel T. Heterosexual HIV and sexual partnerships between injection drug users and noninjection drug users. Aids Patient Care STDs. 2010;24(3):175–81.CrossRefPubMedGoogle Scholar
  11. 11.
    Latkin CA, Forman V, Knowlton A, Sherman S. Norms, social networks, and HIV-related risk behaviors among urban disadvantaged drug users. Soc Sci Med. 2003;56(3):465–76.CrossRefPubMedGoogle Scholar
  12. 12.
    Latkin CA, Mandell W, Vlahov D. The relationship between risk networks’ patterns of crack cocaine and alcohol consumption and HIV-related sexual behaviors among adult injection drug users: A prospective study. Drug Alcohol Depend. 1996;42(3):175–81.CrossRefPubMedGoogle Scholar
  13. 13.
    El-Bassel N, Chen DR, Cooper D. Social support and social network profiles among women on methadone. Soc Serv Rev. 1998;72(3):379–401.CrossRefGoogle Scholar
  14. 14.
    Prentice D, Miller D. Pluralistic ignorance ans alcohol use on campus: some consequences of misperceiving the social norm. J Pers Soc Psychol. 1993;64:243–56.CrossRefPubMedGoogle Scholar
  15. 15.
    Goehl L, Nunes E, Quitkin F, Hilton I. Social networks and methadone treatment outcome: the costs and benefits of social ties. Am J Drug Alcohol Abus. 1993;19(3):251–62.CrossRefGoogle Scholar
  16. 16.
    De P, Cox J, Boivin J-F, Platt RW, Jolly AM. Social network-related risk factors for bloodborne virus infections among injection drug users receiving syringes through secondary exchange. J Urban Health. 2008;85(1):77–89.CrossRefPubMedGoogle Scholar
  17. 17.
    Latkin CA, Davey MA, Hua W. Social context of needle selling in Baltimore, Maryland. Subst Use Misuse. 2006;41(6–7):901–13.CrossRefPubMedGoogle Scholar
  18. 18.
    el-Bassel N, Cooper DK, Chen, Schilling RF. Personal social networks and HIV status among women on methadone. AIDS Care. 1998;10(6):735–49.CrossRefPubMedGoogle Scholar
  19. 19.
    Gordon AJ, Zrull M. Social networks and recovery: one year after inpatient treatment. J Subst Abuse Treat. 1991;8(3):143–52.CrossRefPubMedGoogle Scholar
  20. 20.
    El-Bassel N, Gilbert L, Wu E, Chang M. A social network profile and HIV risk among men on methadone: do social networks matter? J Urban Health. 2006;83(4):602–13.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Latkin C. A persona network approach to AIDS prevention: an experimental peer group intervention for street-injecting drug users: the SAFE study. NIDA Res Monogr. 1995;151:181–95.PubMedGoogle Scholar
  22. 22.
    Neaigus A, Friedman S, Goldstein M, Ildefonso G, Curtis R, Jose B. Using dyadic data for a network analysis of HIV infection and risk behaviors among injecting drug users. NIDA Res Monogr. 1995;151:20–37.PubMedGoogle Scholar
  23. 23.
    Friedman S. Promising social network research results and suggestions for a research agenda. NIDA Res Monogr. 1995;151:196–215.PubMedGoogle Scholar
  24. 24.
    Neaigus A, Friedman SR, Curtis R, Des Jarlais DC, Furst RT, Jose B, et al. The relevance of drug injectors’ social and risk networks for understanding and preventing HIV infection. Soc Sci Med. 1994;38(1):67–78.CrossRefPubMedGoogle Scholar
  25. 25.
    Latkin CA, Mandell W, Vlahov D, Oziemkowska M, Celentano DD. The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: the SAFE study. Am J Commun Psychol. 1996;24(3):341–64.CrossRefGoogle Scholar
  26. 26.
    Miller M, Paone D. Social network characteristics as mediators in the relationship between sexual abuse and HIV risk. Soc Sci Med. 1998;47(6):765–77.CrossRefPubMedGoogle Scholar
  27. 27.
    Adimora AA, Schoenbach VJ, Doherty IA. HIV and African Americans in the southern United States: sexual networks and social context. Sex Transm Dis. 2006;33(7 Suppl):S39–45.CrossRefPubMedGoogle Scholar
  28. 28.
    Young AM, Jonas AB, Mullins UL, Halgin DS, Havens JR. Network structure and the risk for HIV transmission among rural drug users. AIDS Behav. 2013;17(7):2341–51.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Friedman SR, Neaigus A, Jose B, Curtis R, Goldstein M, Ildefonso G, et al. Sociometric risk networks and risk for HIV infection. Am J Public Health. 1997;87(8):1289–96.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Gyarmathy VA, Caplinskiene I, Caplinskas S, Latkin CA. Social network structure and HIV infection among injecting drug users in Lithuania: gatekeepers as bridges of infection. AIDS Behav. 2014;18(3):505–10.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Howard DL, Latkin CA. A bridge over troubled waters: factors associated with non-injection drug users having injection drug-using sex partners. J Acquir Immune Defic Syndr. 2006;42(3):325–30.CrossRefPubMedGoogle Scholar
  32. 32.
    Albarracin D, Tannenbaum MB, Glasman LR, Rothman AJ. Modeling structural, dyadic, and individual factors: the inclusion and exclusion model of HIV related behavior. AIDS Behav. 2010;14(Suppl 2):239–49.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Latkin C, Weeks MR, Glasman L, Galletly C, Albarracin D. A dynamic social systems model for considering structural factors in HIV prevention and detection. AIDS Behav. 2010;14(Suppl 2):222–38.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8:19–32.CrossRefGoogle Scholar
  36. 36.
    Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13(3):141–6.CrossRefPubMedGoogle Scholar
  37. 37.
    Klovdahl AS, Potterat JJ, Woodhouse DE, Muth JB, Muth SQ, Darrow WW. Social networks and infectious disease: the Colorado Springs Study. Soc Sci Med. 1994;38(1):79–88.CrossRefPubMedGoogle Scholar
  38. 38.
    Latkin C, Mandell W, Oziemkowska M, Vlahov D, Celentano D. The relationships between sexual-behavior, alcohol-use, and personal network characteristics among injecting drug-users in Baltimore, Maryland. Sex Transm Dis. 1994;21(3):161–7.CrossRefPubMedGoogle Scholar
  39. 39.
    Johnston D, Stall R, Smith K. Reliance by gay men and intravenous-drug-users on friends and family for AIDS-related care. Aids Care-Psychol Socio-Med Aspects AIDS/HIV. 1995;7(3):307–19.CrossRefGoogle Scholar
  40. 40.
    Latkin C, Mandell W, Oziemkowska M, Celentano D, Vlahov D, Ensminger M, et al. Using social network analysis to study patterns of drug use among urban drug users at high risk for HIV/AIDS. Drug Alcohol Depend. 1995;38(1):1–9.CrossRefPubMedGoogle Scholar
  41. 41.
    Neaigus A, Friedman SR, Jose B, Goldstein MF, Curtis R, Ildefonso G, et al. High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J. Acquir. Immune Defic Syndr Human Retrovirol. 1996;11(5):499–509.CrossRefGoogle Scholar
  42. 42.
    Hoffmann JP, Su SS, Pach A. Changes in network characteristics and HIV risk behavior among injection drug users. Drug Alcohol Depend. 1997;46(1–2):41–51.CrossRefPubMedGoogle Scholar
  43. 43.
    Broadhead R, Heckathorn D, Weakliem D, Anthony D, Madray H, Mills R, et al. Harnessing peer networks as an instrument for AIDS prevention: results from a Peer-Driven intervention. Public Health Rep. 1998;113(Supplement 1):42–57.PubMedPubMedCentralGoogle Scholar
  44. 44.
    Heckathorn D, Broadhead R, Anthony D, Weakliem D. AIDS and social networks: HIV prevention through network mobilization. Sociol Focus. 1998;32:159–79.CrossRefGoogle Scholar
  45. 45.
    Ennett ST, Bailey SL, Federman EB. Social network characteristics associated with risky behaviors among runaway and homeless youth. J Health Soc Behav. 1999;40(1):63–78.CrossRefPubMedGoogle Scholar
  46. 46.
    Servegev B, Oparina T, Rumyantseva TP, Volkanevskii VL, Broadhead RS, Heckathorn DD, et al. HIV prevention in Yaroslavl, Russia: a peer-driven intervention and needle exchange. J. Drug Issues. 1999;29(4):777–804.CrossRefGoogle Scholar
  47. 47.
    Bell DC, Montoya ID, Atkinson JS. Partner concordance in reports of joint risk behaviors. J Acquir Immune Defic Syndr. 2000;25(2):173–81.CrossRefPubMedGoogle Scholar
  48. 48.
    Bell DC, Montoya ID, Atkinson JS, Yang S-J. Social networks and forecasting the spread of HIV infection. J Acquir Immune Defic Syndr. 2002;31(2):218–29.CrossRefPubMedGoogle Scholar
  49. 49.
    Broadhead RS, Heckathorn DD, Altice FL, van Hulst Y, Carbone M, Friedland GH, et al. Increasing drug users’ adherence to HIV treatment: results of a peer-driven intervention feasibility study. Soc Sci Med. 2002;55(2):235–46.CrossRefPubMedGoogle Scholar
  50. 50.
    Friedman SR, Kang SY, Deren S, Robles R, Colon HM, Andia J, et al. Drug-scene roles and HIV risk among Puerto Rican injection drug users in East Harlem, New York and Bayamon, Puerto Rico. J Psychoact Drugs. 2002;34(4):363–9.CrossRefGoogle Scholar
  51. 51.
    Kottiri BJ, Friedman SR, Neaigus A, Curtis R, Des Jarlais DC. Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. J Acquir Immune Defic Syndr. 2002;30(1):95–104.CrossRefPubMedGoogle Scholar
  52. 52.
    Bell DC, Mosier V, Atkinson JS. Protecting oneself from human immunodeficiency virus: are prevention messages being heard? Clin Infect Dis. 2003;37:S433–8.CrossRefPubMedGoogle Scholar
  53. 53.
    Latkin CA, Hua W, Forman VL. The relationship between social network characteristics and exchanging sex for drugs or money among drug users in Baltimore, MD, USA. Int J STD AIDS. 2003;14(11):770–5.CrossRefPubMedGoogle Scholar
  54. 54.
    Latkin CA, Sherman S, Knowlton A. HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychol. 2003;22(4):332–9.CrossRefPubMedGoogle Scholar
  55. 55.
    Knowlton A, Hua W, Latkin C. Social support among HIV positive injection drug users: implications to integrated intervention for HIV positives. AIDS Behav. 2004;8(4):357–63.CrossRefPubMedGoogle Scholar
  56. 56.
    Kang SY, Deren S, Andia J, Colon HM, Robles R. Egocentric HIV risk networks among Puerto Rican crack users in New York and in Puerto Rico: impact on sex risk behaviors over time. AIDS Educ Prev. 2005;17(1):53–67.CrossRefPubMedGoogle Scholar
  57. 57.
    Knowlton AR, Hua W, Latkin C. Social support networks and medical service use among HIV-positive injection drug users: implications to intervention. AIDS Care. 2005;17(4):479–92.CrossRefPubMedGoogle Scholar
  58. 58.
    Broadhead RS, Volkanevsky VL, Rydanova T, Ryabkova M, Borch C, van Hulst Y, et al. Peer-driven HIV interventions for drug injectors in Russia: first year impact results of a field experiment. Int J Drug Policy. 2006;17(5):379–92.CrossRefGoogle Scholar
  59. 59.
    Neaigus A, Gyarmathy VA, Miller M, Frajzyngier VM, Friedman SR, Des Jarlais DC. Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr. 2006;41(4):493–503.CrossRefPubMedGoogle Scholar
  60. 60.
    Friedman SR, Mateu-Gelabert P, Curtis R, Maslow C, Bolyard M, Sandoval M, et al. Social capital or networks, negotiations, and norms? A neighborhood case study. Am J Prev Med. 2007;32(6 Suppl):S160–70.CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Miller M, Korves CT, Fernandez T. The social epidemiology of HIV transmission among African American women who use drugs and their social network members. AIDS Care. 2007;19(7):858–65.CrossRefPubMedGoogle Scholar
  62. 62.
    Needle R, Kroeger K, Belani H, Achrekar A, Parry CD, Dewing S. Sex, drugs, and HIV: rapid assessment of HIV risk behaviors among street-based drug using sex workers in Durban, South Africa. Soc Sci Med. 2008;67(9):1447–55.CrossRefPubMedGoogle Scholar
  63. 63.
    Tobin KE, Latkin CA. An examination of social network characteristics of men who have sex with men who use drugs. Sex Transm Infect. 2008;84(6):420–4.CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Tyler KA. Social network characteristics and risky sexual and drug related behaviors among homeless young adults. Soc Sci Res. 2008;37(2):673–85.CrossRefPubMedGoogle Scholar
  65. 65.
    Abramovitz DV, Volz EM, Strathdee SA, Patterson TL, Vera A, Frost SDW, El Cuete P. Using respondent-driven sampling in a hidden population at risk of HIV infection: who do HIV-positive recruiters recruit? Sex Transm Dis. 2009;36(12):750–6.CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Booth RE, Lehman WEK, Latkin CA, Brewster JT, Sinitsyna L, Dvoryak S. Use of a peer leader intervention model to reduce needle-related risk behaviors among drug injectors in Ukraine. J Drug Issues. 2009;39(3):607–25.CrossRefGoogle Scholar
  67. 67.
    Deering KN, Shannon K, Sinclair H, Parsad D, Gilbert E, Tyndall MW. Piloting a peer-driven intervention model to increase access and adherence to antiretroviral therapy and HIV care among street-entrenched HIV-positive women in Vancouver. AIDS Patient Care STDs. 2009;23(8):603–9.CrossRefPubMedGoogle Scholar
  68. 68.
    Sherman SG, Sutcliffe C, Srirojn B, Latkin CA, Aramratanna A, Celentano DD. Evaluation of a peer network intervention trial among young methamphetamine users in Chiang Mai, Thailand. Soc Sci Med. 2009;68(1):69–79.CrossRefPubMedGoogle Scholar
  69. 69.
    Youm Y, Mackesy-Amiti ME, Williams CT, Ouellet LJ. Identifying hidden sexual bridging communities in Chicago. J Urban Health. 2009;86(Suppl 1):107–20.CrossRefPubMedPubMedCentralGoogle Scholar
  70. 70.
    Hahn JA, Evans JL, Davidson PJ, Lum PJ, Page K. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users. Addiction. 2010;105(7):1254–64.CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    Latkin C, Yang C, Tobin K, Hulbert A. Factors associated with recruiting an HIV seropositive risk network member among injection drug users. Aids Behav. 2010;14(5):1137–41.CrossRefPubMedPubMedCentralGoogle Scholar
  72. 72.
    Tyler K, Melander L. The effect of drug and sexual risk behaviours with social network and non-network members on homeless youths’ sexually transmissible infections and HIV testing. Sex Health. 2010;7(4):434–40.CrossRefPubMedGoogle Scholar
  73. 73.
    Booth RE, Lehman WEK, Latkin CA, Dvoryak S, Brewster JT, Royer MS, et al. Individual and network interventions with injection drug users in 5 Ukraine cities. Am J Public Health. 2011;101(2):336–43.CrossRefPubMedPubMedCentralGoogle Scholar
  74. 74.
    Davey-Rothwell MA, Chander G, Hester L, Latkin CA. Social network characteristics and heavy episodic drinking among women at risk for HIV/sexually transmitted infections. J Stud Alcohol. 2011;72(6):1041–7.CrossRefGoogle Scholar
  75. 75.
    Gyarmathy VA, Li N, Tobin KE, Hoffman IF, Sokolov N, Levchenko J, Batluk J, Kozlov AA, Kozlov AP, Latkin CA. Unprotected sex in heterosexual partnerships of injecting drug users in st. Petersburg, Russia. AIDS Behav. 2011;15(1):58–64.CrossRefPubMedPubMedCentralGoogle Scholar
  76. 76.
    Latkin C, Yang C, Srikrishnan AK, Solomon S, Mehta SH, Celentano DD, Kumar MS, Knowlton A, Solomon SS. The relationship between social network factors, HIV, and Hepatitis C among injection drug users in Chennai, India. Drug Alcohol Depend. 2011;117(1):50–4.CrossRefPubMedPubMedCentralGoogle Scholar
  77. 77.
    Li J, Liu H, Li J, Luo J, Koram N, Detels R. Sexual transmissibility of HIV among opiate users with concurrent sexual partnerships: an egocentric network study in Yunnan, China. Addiction. 2011;106(10):1780–7; discussion 1788–9.Google Scholar
  78. 78.
    Li J, Weeks MR, Borgatti SP, Clair S, Dickson-Gomez J. A social network approach to demonstrate the diffusion and change process of intervention from peer health advocates to the drug using community. Subst Use Misuse. 2012;47(5):474–90.CrossRefPubMedPubMedCentralGoogle Scholar
  79. 79.
    Richardson L, Grund T. Modeling the impact of supra-structural network nodes: the case of anonymous syringe sharing and HIV among people who inject drugs. Soc Sci Res. 2012;41(3):624–36.CrossRefPubMedGoogle Scholar
  80. 80.
    Smyrnov P, Broadhead RS, Datsenko O, Matiyash O. Rejuvenating harm reduction projects for injection drug users: Ukraine’s nationwide introduction of peer-driven interventions. Int J Drug Policy. 2012;23(2):141–7.CrossRefPubMedGoogle Scholar
  81. 81.
    Adams J, Moody J, Morris M. Sex, drugs, and race: how behaviors differentially contribute to the sexually transmitted infection risk network structure. Am J Public Health. 2013;103(2):322–9.CrossRefPubMedPubMedCentralGoogle Scholar
  82. 82.
    Brown RA, Kennedy DP, Tucker JS, Golinelli D, Wenzel SL. Monogamy on the street a mixed methods study of homeless men. J Mixed Methods Res. 2013;7(4):328–46.CrossRefGoogle Scholar
  83. 83.
    Eritsyan K, Heimer R, Barbour R, Odinokova V, White E, Rusakova MM, et al. Individual-level, network-level and city-level factors associated with HIV prevalence among people who inject drugs in eight Russian cities: a cross-sectional study. BMJ Open. 2013;3(6):e002645.CrossRefPubMedPubMedCentralGoogle Scholar
  84. 84.
    Green HD Jr, de la Haye K, Tucker JS, Golinelli D. Shared risk: who engages in substance use with American homeless youth? Addiction. 2013;108(9):1618–24.CrossRefPubMedGoogle Scholar
  85. 85.
    Guo W, Bao SL, Lin W, Wu GH, Zhang W, Hladik W, et al. Estimating the size of HIV key affected populations in Chongqing, China, using the network scale-up method. PLoS One. 2013;8(8):e71796.CrossRefPubMedPubMedCentralGoogle Scholar
  86. 86.
    Latkin C, Davey-Rothwell M, Yang JY, Crawford N. The relationship between drug user stigma and depression among inner-city drug users in Baltimore, MD. J Urban Health. 2013;90(1):147–56.CrossRefPubMedGoogle Scholar
  87. 87.
    Latkin C, Donnell D, Liu T-Y, Davey-Rothwell M, Celentano D, Metzger D. The dynamic relationship between social norms and behaviors: the results of an HIV prevention network intervention for injection drug users. Addiction. 2013;108(5):934–43.CrossRefPubMedPubMedCentralGoogle Scholar
  88. 88.
    White K, Rudolph AE, Jones KC, Latkin C, Benjamin EO, Crawford ND, et al. Social and individual risk determinants of HIV testing practices among noninjection drug users at high risk for HIV/AIDS. AIDS Care. 2013;25(2):230–8.CrossRefPubMedGoogle Scholar
  89. 89.
    Williams C, Eisenberg M, Becher J, Davis-Vogel A, Fiore D, Metzger D. Racial disparities in HIV prevalence and risk behaviors among injection drug users and members of their risk networks. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2013;63:S90–4.CrossRefGoogle Scholar
  90. 90.
  91. 91.
    Broadhead RS, Heckathorn DD, Weakliem DL, Anthony DL, Madray H, Mills RJ, et al. Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep. 1998;113(Suppl 1):42–57.PubMedPubMedCentralGoogle Scholar
  92. 92.
    Latkin CA, Davey-Rothwell MA, Knowlton AR, Alexander KA, Williams CT, Boodram B. Social network approaches to recruitment, HIV prevention, medical care, and medication adherence. J Acquir Immune Defic Syndr. 2013;63(Suppl 1):S54–8.CrossRefPubMedPubMedCentralGoogle Scholar
  93. 93.
    De Cock KM, Crowley SP, Lo YR, Granich RM, Williams BG. Preventing HIV transmission with antiretrovirals. Bull World Health Organ. 2009;87(7):488–488A.CrossRefPubMedPubMedCentralGoogle Scholar
  94. 94.
    Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373(9657):48–57.CrossRefPubMedGoogle Scholar
  95. 95.
    Montaner JS. Treatment as prevention: toward an AIDS-free generation. Top Antivir Med. 2013;21(3):110–4.PubMedGoogle Scholar
  96. 96.
    Broadhead RS, Borch C, Hulst YV, Gauchat G, Tehrani S, Stringer KL, et al. Relying on injection drug users to access and adhere to HIV therapeutics: bittersweet lessons using respondent-driven sampling and a peer-driven intervention. J Drug Issues. 2012;42(2):127–46.CrossRefGoogle Scholar
  97. 97.
    Wang K, Brown K, Shen SY, Tucker J. Social network-based interventions to promote condom use: a systematic review. AIDS Behav. 2011;15(7):1298–308.CrossRefPubMedPubMedCentralGoogle Scholar
  98. 98.
    Simmons N, Donnell D, Ou SS, Celentano DD, Aramrattana A, Davis-Vogel A, et al. Assessment of contamination and misclassification biases in a randomized controlled trial of a social network peer education intervention to reduce HIV risk behaviors among drug users and risk partners in Philadelphia, PA and Chiang Mai, Thailand. AIDS Behav. 2015;19(10):1818–27.CrossRefPubMedPubMedCentralGoogle Scholar
  99. 99.
    Anderson S, Allen P, Peckham S, Goodwin N. Asking the right questions: scoping studies in the commissioning of research on the organisation and delivery of health services. Health Res Policy Syst. 2008;6:7.CrossRefPubMedPubMedCentralGoogle Scholar
  100. 100.
    Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5:69.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Debarchana Ghosh
    • 1
  • Archana Krishnan
    • 2
  • Britton Gibson
    • 3
  • Shan-Estelle Brown
    • 3
  • Carl A. Latkin
    • 4
  • Frederick L. Altice
    • 3
    • 5
    • 6
  1. 1.Department of Geography and Institute for Collaboration on Health Intervention and PreventionUniversity of ConnecticutStorrsUSA
  2. 2.Department of CommunicationUniversity at Albany, SUNYAlbanyUSA
  3. 3.Section of Infectious Diseases in AIDS Program, Department of Internal Medicine, Yale School of MedicineYale UniversityNew HavenUSA
  4. 4.Department of Health, Behavior, and Society, EpidemiologyJohns Hopkins University-Bloomberg School of Public HealthBaltimoreUSA
  5. 5.Division of Epidemiology of Microbial Diseases, Yale School of Public HealthYale UniversityNew HavenUSA
  6. 6.Centre of Excellence on Research in AIDS (CERiA)University of MalayaKuala LumpurMalaysia

Personalised recommendations